Literature DB >> 1092585

Comparative effects of metoclopramide and bethanechol on lower esophageal sphincter pressure in reflux patients.

R W McCallum, M M Kline, N Curry, R A Sturdevant.   

Abstract

The effects of oral metoclopramide, 10 and 20 mg, bethanechol, 25 mg, and placebo on lower esophageal sphincter pressure (LESP) were studied in 15 men with symptoms of gastroesophageal reflux and basal LESP less than 11 mm Hg. Each drug produced a significant increase in LESP when compared to placebo. Metoclopramide, 20 mg, produced a greater increase than either metoclopramide, 10 mg, or bethanechol, 25 mg. Serum gastrin concentrations were not altered by any of the drugs. Side effects were unremarkable. The LESP increasing effect of metoclopramide might be useful in treatment of gastro-esophageal reflux.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1092585

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

1.  Serum gastrin concentrations following oral bethanechol with and without a meal.

Authors:  T J Humphries; R H Higgs; D O Castell; J E Mcguigan
Journal:  Am J Dig Dis       Date:  1978-03

Review 2.  Overlap of functional dyspepsia and GERD--diagnostic and treatment implications.

Authors:  Eamonn M M Quigley; Brian E Lacy
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-08       Impact factor: 46.802

3.  Lack of effect of metoclopramide and domperidone on esophageal peristalsis and esophageal acid clearance in reflux esophagitis. A randomized, double-blind study.

Authors:  L Grande; G Lacima; E Ros; J C García-Valdecasas; J Fuster; J Visa; C Pera
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

4.  Effect of bethanechol on gastric acid secretion and serum gastrin concentration after proximal gastric vagotomy.

Authors:  M Feldman; J H Walsh
Journal:  Ann Surg       Date:  1982-07       Impact factor: 12.969

5.  L-Dopa inhibits metoclopramide stimulation of the lower esophageal sphincter in man.

Authors:  H W Baumann; A L Sturdevant; R W McCallum
Journal:  Dig Dis Sci       Date:  1979-04       Impact factor: 3.199

Review 6.  Metoclopramide: a review of its pharmacological properties and clinical use.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 7.  Medical treatment of esophageal motility disorders.

Authors:  H D Allescher; W J Ravich
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

8.  Effect of metoclopramide on normal and delayed gastric emptying in gastroesophageal reflux patients.

Authors:  S M Fink; R C Lange; R W McCallum
Journal:  Dig Dis Sci       Date:  1983-12       Impact factor: 3.199

9.  Guaiacol -- a new compound in the treatment of gastro-oesophageal reflux?

Authors:  R V Heatley; B K Evans; J Rhodes; M Atkinson
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

10.  Effect of atropine on vagal release of gastrin and pancreatic polypeptide.

Authors:  M Feldman; C T Richardson; I L Taylor; J H Walsh
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.